The Average Worker Thinks Retirement Will Cost Them $1.8 Million. Can Social Security Cover It All?
https://www.fool.com/retirement/2024/03/17/the-average-worker-thinks-retirement-will-cost/?source=iedfolrf0000001
Mar 17, 2024 - You don't want to be overly optimistic here.
0
AstraZeneca to cap costs of inhalers at $35 per month
https://seekingalpha.com/news/4080619-astrazeneca-to-cap-costs-of-inhalers-at-35-per-month?source=feed_sector_healthcare
Mar 18, 2024 - AstraZeneca (AZN) plans to cap out-of-pocket costs for its inhalers at $35 per month following Congressional criticism of its pricing of the products in the US. Read more here.
0
Southern Copper (SCCO) Bets on Strong Projects Amid Cost Woes
https://www.zacks.com/stock/news/2242399/southern-copper-scco-bets-on-strong-projects-amid-cost-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2242399
Mar 18, 2024 - Southern Copper (SCCO) is poised to grow on the back of its copper reserves and solid growth projects. However, inflationary pressures will impact margins in the near term.
0
JetBlue cuts routes spanning Los Angeles to Lima in race to lower costs
https://www.cnbc.com/2024/03/19/jetblue-cuts-routes-los-angeles-south-america.html
Mar 19, 2024 - JetBlue is under increased pressure to reduce expenses and return to profitability.
0
East West Bancorp (EWBC) Rides on High Rates Amid Rising Costs
https://www.zacks.com/stock/news/2242982/east-west-bancorp-ewbc-rides-on-high-rates-amid-rising-costs?cid=CS-ZC-FT-analyst_blog|zer_report_update-2242982
Mar 19, 2024 - East West Bancorp (EWBC) remains well-poised for growth amid decent loan demand, high rates and continued client acquisition efforts. However, elevated expenses and poor asset quality are worrisome.
0
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
https://www.zacks.com/stock/news/2243035/astrazeneca-azn-follows-boehringer-to-cap-inhaler-cost-in-us?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243035
Mar 19, 2024 - AstraZeneca (AZN) plans to lower the prices of its inhaled respiratory products to $35 per month in the United States. However, the company intends to start this in June 2024.
0
Regions Financial (RF) Rides on Loan Growth, High Costs Ail
https://www.zacks.com/stock/news/2242846/regions-financial-rf-rides-on-loan-growth-high-costs-ail?cid=CS-ZC-FT-analyst_blog|zer_report_update-2242846
Mar 19, 2024 - Regions Financial (RF) benefits from consistent growth in loan balances and strategic buyouts. However, rising expenses and lack of loan portfolio diversification are major headwinds.
0
A new plan for Midwest power lines could cost $23 billion. Is it enough?
https://www.startribune.com/a-new-plan-for-midwest-power-lines-could-cost-23-billion-is-it-enough/600352358/
Mar 19, 2024 - Some experts have called a colossal new proposal for more than a dozen power lines in the region sparse.
0
The Federal Reserve holds interest rates steady, with no immediate relief for consumers from sky-high borrowing costs
https://www.cnbc.com/2024/03/20/the-fed-holds-interest-rates-steady-what-that-means-for-your-money.html
Mar 20, 2024 - As the Federal Reserve postpones rate cutting, here's what that means for your credit card, mortgage rate, auto loan and savings account.
0
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
https://www.zacks.com/stock/news/2244405/gsk-follows-rivals-to-cap-out-of-pocket-inhaler-cost-in-us?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2244405
Mar 21, 2024 - GSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month in the United States. The company intends to start this in 2025.
0